trending Market Intelligence /marketintelligence/en/news-insights/trending/ovg3sg_uTwiArbFDvCEavg2 content esgSubNav
In This List

US FDA clears IRadimed's MRI-compatible IV infusion pump

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


US FDA clears IRadimed's MRI-compatible IV infusion pump

IRadimed Corp. received the U.S. FDA's 510(k) clearance for its MRidium 3860+ MRI-compatible IV infusion pump system, including its dose error reduction system software feature.

The system provides fluid delivery before, during and after an MRI scan. The dose error reduction system software allows users to create a unique drug library and set nominal values and limits for dose and concentration for specified infusion protocols.